These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24056557)

  • 21. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM; Shirey RS; Thoman SK; Jackson JB
    Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn.
    Singh B; Chaudhary R; Katharia R
    Transfus Apher Sci; 2021 Feb; 60(1):102958. PubMed ID: 33039278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India.
    Gothwal M; Singh P; Bajpayee A; Agrawal N; Yadav G; Sharma C
    Obstet Gynecol Sci; 2023 Mar; 66(2):84-93. PubMed ID: 36444517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irregular erythrocyte antibodies among antenatal women and their neonatal outcome at a tertiary care hospital in Northern India.
    Mandal S; Kaur D; Negi G; Basu S; Chaturvedi J; Maji M; Malhotra S
    Postgrad Med J; 2023 May; 99(1169):145-152. PubMed ID: 37222058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does high body mass index (>25 kg/m
    Ngan CBM; Kaur R; Jackson DE
    Vox Sang; 2024 Jun; ():. PubMed ID: 38889996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous drug use is associated with alloimmunization in pregnancy.
    Lappen JR; Stark S; Gibson KS; Prasad M; Bailit JL
    Am J Obstet Gynecol; 2016 Sep; 215(3):344.e1-6. PubMed ID: 26996989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of unexpected red blood cell antibodies in pregnant women and follow-up of pregnancy outcome in pregnant women treated with intra-uterine transfusion.
    Golia S; Tiwari AK; Aggarwal G; Khetrapal A; Tyagi SK; Jain C; Gupta S; Pawar S
    Asian J Transfus Sci; 2024; 18(1):45-50. PubMed ID: 39036694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Jk-b Antibodies and Hemolytic Disease of the Fetus and Newborn: Case-Based Learning.
    R A; V S; I SK; Haran A H; James S
    Cureus; 2024 Jun; 16(6):e61948. PubMed ID: 38978942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan.
    Moinuddin I; Fletcher C; Millward P
    J Blood Med; 2019; 10():283-289. PubMed ID: 31692490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region].
    Holusková I; Lubušký M; Studničková M; Procházka M
    Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal red blood cell alloimmunisation in south western Uganda.
    Natukunda B; Mugyenyi G; Brand A; Schonewille H
    Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red cell alloimmunization & role of advanced immunohaematological support in liver transplantation.
    Makroo RN; Agrawal S; Chowdhry M; Bhatia A; Thakur UK
    Indian J Med Res; 2017 Apr; 145(4):488-491. PubMed ID: 28862180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study.
    Bollason G; Hjartardottir H; Jonsson T; Gudmundsson S; Kjartansson S; Halldorsdottir AM
    Transfusion; 2017 Nov; 57(11):2578-2585. PubMed ID: 28840609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red Blood Cell Alloimmunization in the Pregnant Patient.
    Webb J; Delaney M
    Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.